Literature DB >> 29430803

An initial experience with an Extraluminal EZ-Blocker® : A new alternative for 1-lung ventilation in pediatric patients.

Thomas Wesley Templeton1, Leah B Templeton1, Ann E Lawrence1, Leah M Sieren2, Martina G Downard1, Douglas G Ririe1.   

Abstract

BACKGROUND: The need for 1-lung ventilation in school age, pediatric patients is uncommon and as a result there are relatively few devices available to facilitate lung isolation in this population. Furthermore, little is known about the efficacy and techniques of placement of the currently available devices. One of the newest devices available that may be appropriate in this age group is the EZ-Blocker. AIMS: We aimed to examine our initial experience with the EZ-Blocker to evaluate the performance of this device with respect to potential improvements in technique and patient selection going forward.
METHODS: We performed a retrospective chart review of all pediatric patients who underwent 1-lung ventilation with an EZ-Blocker since the blocker became available at our institution. We recorded demographics, details of placement, intraoperative course, number of repositions, and any postoperative morbidity related to blocker placement or 1-lung ventilation.
RESULTS: We were able to correctly place the EZ-Blocker and achieve lung isolation in 8 of 11 patients. There was a single episode of repositioning required during 1-lung ventilation with an EZ-Blocker.
CONCLUSION: The EZ-Blocker was successful in providing lung isolation for a majority of our school age patients. Size constraints in children <6 years of age, excessive secretions, and distortions of tracheal anatomy seemed to be the greatest hindrances to successful placement and positioning of the device. Once correctly positioned, however, the EZ-Blocker may be more stable than the Arndt endobronchial blocker.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  EZ-blocker; bronchial blocker; lung isolation; pediatric 1-lung ventilation; pediatric anesthesia

Mesh:

Year:  2018        PMID: 29430803     DOI: 10.1111/pan.13342

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

1.  Use of Fogarty catheter as bronchial blocker for lung isolation in children undergoing thoracic surgery: A single centre experience of 15 cases.

Authors:  Bikram K Behera; Satyajeet Misra; Manoj K Mohanty; Bikasha B Tripathy
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

2.  The EZ-blocker for one-lung ventilation in patients undergoing thoracic surgery: clinical applications and experience in 100 cases in a routine clinical setting.

Authors:  Andreas Moritz; Andrea Irouschek; Torsten Birkholz; Johannes Prottengeier; Horia Sirbu; Joachim Schmidt
Journal:  J Cardiothorac Surg       Date:  2018-06-25       Impact factor: 1.637

3.  Selective pulmonary lobe isolation with Arndt pediatric endobronchial blocker for an infant: A case report.

Authors:  Chaomeng Wu; Xiao Liang; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Effects of bronchial blockers on gas exchange in infants with one-lung ventilation: a single-institutional experience of 22 cases.

Authors:  Li Zhang; Yu-Ping Wang; Xiao-Fen Chen; Zi-Rogn Yan; Min Zhou
Journal:  Transl Pediatr       Date:  2020-12

Review 5.  Challenge of Lung Isolation in Patients with Vocal Cord Implants.

Authors:  Islam Mohammad Shehata; Amir Elhassan; Behrooz Zaman; Omar Viswanath
Journal:  Anesth Pain Med       Date:  2022-03-22

6.  Comparison of left double lumen tube and y-shaped and double-ended bronchial blocker for one lung ventilation in thoracic surgery-a randomised controlled clinical trial.

Authors:  Joachim Risse; Karsten Szeder; Ann-Kristin Schubert; Thomas Wiesmann; Hanns-Christian Dinges; Carsten Feldmann; Hinnerk Wulf; Karl Matteo Meggiolaro
Journal:  BMC Anesthesiol       Date:  2022-04-02       Impact factor: 2.217

7.  Cryoanalgesia and Lung Isolation: A New Challenge for the Nuss Procedure Made Easier With the EZ-Blocker™.

Authors:  Nicole McCoy; Laura Hollinger
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.